SCHEMBL7856181

SCHEMBL7856181

[CH]=CCCOc1cccc(Cl)c1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.54
MAPK1 P28482 1/20 0.54
HTT P42858 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
DRD2 P14416 1/20 0.51
DRD4 P21917 1/20 0.51
KMT2A Q03164 3/20 0.50
KCNH2 Q12809 1/20 0.50
KDM4E B2RXH2 2/20 0.48
MEN1 O00255 1/20 0.48
WDR5 P61964 1/20 0.47
HRH3 Q9Y5N1 3/20 0.47
CYP2D6 P10635 1/20 0.47
MAOB P27338 1/20 0.45
AOC3 Q16853 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9808215 0.82 LMNA (0.67) LMNAMAPK1HTTSMN1; SMN2DRD2
SCHEMBL97532 0.82 DRD2 (0.55) LMNAMAPK1HTTSMN1; SMN2DRD2
SCHEMBL2000837 0.79 LMNA (0.59) LMNAMAPK1HTTSMN1; SMN2DRD2
SCHEMBL31267597 0.77 DRD2 (0.54) LMNAMAPK1HTTSMN1; SMN2DRD2
SCHEMBL9808100 0.77 DRD2 (0.72) LMNAMAPK1HTTSMN1; SMN2DRD2
SCHEMBL1685432 0.77 DRD2 (0.62) LMNAMAPK1HTTSMN1; SMN2DRD2
SCHEMBL3957187 0.77 LMNA (0.61) LMNAMAPK1HTTSMN1; SMN2DRD2
SCHEMBL11519069 0.77 DRD4 (0.44) SMN1; SMN2DRD2DRD4KCNH2HRH3
SCHEMBL4993415 0.77 KCNA3 (0.58) DRD2DRD4
SCHEMBL2096611 0.76 KMT2A (0.62) LMNAMAPK1HTTSMN1; SMN2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0660716-B1 NON-ACIDIC CYCLOPENTANE HEPTANOIC ACID, 2-CYCLOALKYL OR ARYLALKYL DERIVATIVES AS THERAPEUTIC AGENTS ALLERGAN INC (US) 2001-11-28 EP disclosed
US-5607978-A PROSTAGLANDINS FOR VISION DEFECTS ALLERGAN (US) 1997-03-04 US disclosed
EP-0660716-A1 NON-ACIDIC CYCLOPENTANE HEPTANOIC ACID, 2-CYCLOALKYL OR ARYLALKYL DERIVATIVES AS THERAPEUTIC AGENTS ALLERGAN, INC. (US) 1995-07-05 EP disclosed
US-5352708-A For treating glaucoma ALLERGAN, INC. (US) 1994-10-04 US disclosed
US-RE29926-E 2-Decarboxy-2-hydroxy-methyl-16-fluoro-PGE1 compounds THE UPJOHN COMPANY (US) 1979-03-06 US disclosed
US-4122282-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-10-24 US disclosed
US-4107191-A PROSTAGLANDINS, BLOOD PRESSURE LOWERING, LABOR INDUCTION, REPRODUCTIVE-CYCLE REGULATION, GASTRIC ANTISECRETORY THE UPJOHN COMPANY (US) 1978-08-15 US disclosed
US-4104474-A PROSTAGLANDINS, HYPOTENSIVE, OXYTOCICS, ANTIFERTILITY, ANTISECRETORY THE UPJOHN COMPANY (US) 1978-08-01 US disclosed
US-4099014-A BLOOD PLATELET AGGREGATION INHIBITORS THE UPJOHN COMPANY (US) 1978-07-04 US disclosed
US-4099015-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-07-04 US disclosed
US-4073808-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-02-14 US disclosed
US-4058564-A PROSTAGLANDINS; HYPOTENSIVE, LABOR INDUCERS, ANTISECRETORY THE UPJOHN COMPANY (US) 1977-11-15 US disclosed
US-4055602-A PROSTAGLANDIN THE UPJOHN COMPANY (US) 1977-10-25 US disclosed
US-4033989-A 9-Deoxy-PGF2 Analogs THE UPJOHN COMPANY (US) 1977-07-05 US disclosed
US-4029681-A 13,14-Didehydro-PG analogs THE UPJOHN COMPANY (US) 1977-06-14 US disclosed
US-4028419-A PROSTAGLANDINS THE UPJOIN COMPANY (US) 1977-06-07 US disclosed
US-4026909-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1977-05-31 US disclosed
US-4018803-A 13,14-Didehydro-PG3 compounds THE UPJOHN COMPANY (US) 1977-04-19 US disclosed
US-4016184-A PROSTAGLANDINS, BLOOD PLATELET AGGREGATION INHIBITORS THE UPJOHN COMPANY (US) 1977-04-05 US disclosed
US-4013695-A PROSTAGLANDINS, HYPOTENSIVES, OXYTOCICS, ANTISECRETORY AND ANTIULCER AGENTS, REPRODUCTION CONTROL THE UPJOHN COMPANY (US) 1977-03-22 US disclosed